Adherence to hypertension and dyslipidemia treatment and its implication on control of cardiovascular disease in Vietnam: A semi-systematic review

Abstract

Background: To understand the prevalent issues and challenges in the provision of care for dyslipidemia and hypertension in Vietnamese adults, quantification of patient journey stages (awareness, screening, diagnosis, treatment, adherence, and control) was performed in this semi-systematic review. Methods: The EMBASE and MEDLINE databases were searched for English articles published between 2010 and 2019. Thesis abstracts, letters to the editor, editorials, case studies, and studies on patient subgroups or nationally unrepresentative studies, were excluded. Articles from Google, the Incidence and Prevalence Database, the World Health Organization, Vietnam’s Ministry of Health, and those suggested by the authors were also included. The last search was run on December 10, 2019 for dyslipidemia and hypertension. Results: A reviewer independently screened 586 retrievals for dyslipidemia and 177 retrievals for hypertension, and extracted data from 2 articles on dyslipidemia and 6 articles on hypertension that were included in the final synthesis. Conclusion: The data generated in this review will help overcome these issues and barriers to patient care in populations with these 2 conditions.

Advances in Research on Marine-Derived Lipid-Lowering Active Substances and Their Molecular Mechanisms

“…Among the types of non-communicable diseases, Cardiovascular disease (CVD) is the leading cause of morbidity and mortality, affecting over 523 million people globally [2]. Dyslipidemia and hypertension are the main risk factors for CVD [3]. Hyperlipidemia is a systemic metabolic abnormality caused by genetically or environmentally induced increases in plasma levels of cholesterol, triglycerides, and low-density lipoproteins and decreases in high-density lipoproteins.…”